万乃洛韦联合紫外线照射治疗玫瑰糠疹疗效观察

Observation on Therapeutic Effect on Valaciclovir Alliance With Ultraviolet in Patients with Pityriasis Rosea

目的观察万乃洛韦联合紫外线照射治疗玫瑰糠疹的疗效。方法将93例患者随机分为两组,治疗组60例口服万乃洛韦300mg 2次/d,连续10天;对照组33例口服左西替利嗪10mg 1次/d,维生素C 0.2g 3次/d,葡萄糖酸钙1.0g 3次/d,连续10天。两组均同时隔日一次局部紫外线照射。结果治疗组有效率为83.33%,对照组为57.57%,二者差异有显著性(P<0.01)。结论万乃洛韦联合紫外线照射治疗玫瑰糠疹的疗效好。

Objective To evaluate effects of valaciclovir therapeutic alliance with ultraviolet in patients with Pityriasis rosea. Methods A total of 93 patients with pityriasis rosea, was divided into two groups randomly： Treatment group（ n = 60）administration with valaeiclovir（300mg, one day twice） ;Control group（ n = 33 ）administration with levoeetirizine（ 10mg）, vitC （200mg）and calcium glueonate（1g） , Course of treatment was 10days. All patients recieved region ultraviolet every other day. Results The efficacy rate of treatment group was 83.33% and the other group was 57.57% , There was a significant difference between the two groups （ P 〈 0.01 ）. Conclusions Valaeielovir therapeutic alliance with ultraviolet was surpass levocetirizine in patients with Pityriasis rosea.